Skip to main content
Fig. 11 | 3D Printing in Medicine

Fig. 11

From: Urgent need hybrid production - what COVID-19 can teach us about dislocated production through 3d-printing and the maker scene

Fig. 11

Altered life cycle for a medical device with in-house production and disinfection or recycling after usage. Only the raw material for production will be delivered to the hospital. After production and the subsequent quality assurance, the products are ready for use. After usage, the products undergo disinfection and, if desired, are reused. Otherwise, the waste is recycled or disposed

Back to article page

3D Printing in Medicine

ISSN: 2365-6271

Contact us